These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35049438)

  • 21. IL‑21/IL‑21R inhibit tumor growth and invasion in non‑small cell lung cancer cells via suppressing Wnt/β‑catenin signaling and PD‑L1 expression.
    Xue D; Yang P; Wei Q; Li X; Lin L; Lin T
    Int J Mol Med; 2019 Nov; 44(5):1697-1706. PubMed ID: 31573051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Molecular mechanism of Spatholobi Caulis in treatment of lung cancer based on network pharmacology and molecular docking].
    Chen K; Jin C; Cheng YY; Zhang QX; Li XX; Zhang L
    Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):837-844. PubMed ID: 33645088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The long non-coding RNA PVT1/miR-145-5p/ITGB8 axis regulates cell proliferation, apoptosis, migration and invasion in non-small cell lung cancer cells.
    Wei CM; Zhao XF; Qiu HB; Ming Z; Liu K; Yan J
    Neoplasma; 2020 Jul; 67(4):802-812. PubMed ID: 32202906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silencing of
    Zhang P; Li Z; Yang G
    Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34713300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signaling.
    Li JX; Li RZ; Sun A; Zhou H; Neher E; Yang JS; Huang JM; Zhang YZ; Jiang ZB; Liang TL; Ma LR; Wang J; Wang XR; Fan XQ; Huang J; Xie Y; Liu L; Tang L; Leung EL; Yan PY
    Pharmacol Res; 2021 Sep; 171():105574. PubMed ID: 34419228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated Network Pharmacology and Experimental Verification to Explore the Molecular Mechanism of Hedysarum Multijugum Maxim-Curcumae Rhizoma Herb Pair for Treating Non-Small Cell Lung Cancer.
    Hu S; Ge M; Zhang S; Jiang M; Hu K; Gao L
    Front Oncol; 2022; 12():854596. PubMed ID: 35433443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway.
    Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silence of fibronectin 1 increases cisplatin sensitivity of non-small cell lung cancer cell line.
    Gao W; Liu Y; Qin R; Liu D; Feng Q
    Biochem Biophys Res Commun; 2016 Jul; 476(1):35-41. PubMed ID: 27207836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Linc00460 on cell migration and invasion through regulating epithelial-mesenchymal transition (EMT) in non-small cell lung cancer.
    Yue QY; Zhang Y
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1003-1010. PubMed ID: 29509248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-185-5p targets RAB35 gene to regulate tumor cell-derived exosomes-mediated proliferation, migration and invasion of non-small cell lung cancer cells.
    Wen H; Liu Z; Tang J; Bu L
    Aging (Albany NY); 2021 Sep; 13(17):21435-21450. PubMed ID: 34500436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
    J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bufalin inhibits the malignant development of non-small cell lung cancer by mediating the circ_0046264/miR-522-3p axis.
    Jin J; Yao Z; Qin H; Wang K; Xin X
    Biotechnol Lett; 2021 Jun; 43(6):1229-1240. PubMed ID: 33534015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of miR-758 inhibited proliferation, migration, invasion, and promoted apoptosis of non-small cell lung cancer cells by negatively regulating HMGB.
    Zhou GH; Lu YY; Xie JL; Gao ZK; Wu XB; Yao WS; Gu WG
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30446524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ACTL6A promotes the growth in non-small cell lung cancer by regulating Hippo/Yap pathway.
    Ma L; Shan L
    Exp Lung Res; 2021; 47(5):250-259. PubMed ID: 33896314
    [No Abstract]   [Full Text] [Related]  

  • 37. Pulsatilla saponin E suppresses viability, migration, invasion and promotes apoptosis of NSCLC cells through negatively regulating Akt/FASN pathway
    Zhu M; Shi W; Chen K; Hu H; Ye X; Jiang Y
    J Recept Signal Transduct Res; 2022 Feb; 42(1):23-33. PubMed ID: 33243063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. lncRNA AFAP1-AS1 Promotes Migration and Invasion of Non-Small Cell Lung Cancer via Up-Regulating IRF7 and the RIG-I-Like Receptor Signaling Pathway.
    Tang XD; Zhang DD; Jia L; Ji W; Zhao YS
    Cell Physiol Biochem; 2018; 50(1):179-195. PubMed ID: 30278439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction and validation of common targets in atherosclerosis and non-small cell lung cancer influenced by atorvastatin.
    Li YQ; Li LY; Yang X; Lei QQ; Xiang LY; Wang YR; Gu SM; Cao YJ; Pan Y; Tie L; Li XJ
    BMC Complement Med Ther; 2023 Nov; 23(1):415. PubMed ID: 37978381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.